Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma

Diseases of the Colon and Rectum

Volumn 54, Issue 4, 2011, Pages 401-411

  Topova, Larysa ^a   Hellmich, Gunter ^a   Puffer, Erik ^a   Schubert, Clemens ^a   Christen, Norbert ^a   Boldt, Thomas ^a   Wiedemann, Baerbel ^b   Witzigmann, Helmut ^a   Stelzner, Sigmar ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Chemoradiotherapy; Neoadjuvant treatment; Prognostic factors; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; RECTUM CARCINOMA; RECTUM RESECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 79956159481     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3182070efb     Document Type: Article

References (44)

1. Hermanek P. Prognostic factor research in oncology.J Clin Epi-demiol. 1999;52:371-374. (Pubitemid 29305309)
2. Gospodarowicz MK, O'Sullivan B. Prognostic factors:principles and application. In: Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind C, eds. Prognostic Factors in Cancer. 2nd ed. New York, NY: Wiley-Liss; 2001:17-35.
3. Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH, eds Prognostic Factors in Cancer. 1st ed. Berlin: Springer; 1995.
4. Gospodarowicz MK, O'Sullivan B, Sobin LH, eds. Prognostic Factors in Cancer. 3ded. Hoboken, NJ: John Wiley &Sons; 2006.
5. Sobin LH, Witteckind C, eds. International Union Against Can-cer (UICC). TNM Classification ofMalignant Tumors. 5th ed. New York, NY: Wiley-Liss; 1997.
6. Castaldo ET, Parikh AA, Pinson CW, Feurer ID, Merchant NB. Improvement of survival with response to neoadjuvant radia-tion therapy for rectal cancer. Arch Surg. 2009;144:129-135.
7. Mason AY. President's address. Rectal cancer: the spectrum of selective surgery. Proc R Soc Med. 1976;69:237-244. (Pubitemid 8127217)
8. Brown G, Richards CJ, Bourne MW, et al. Morphologic predic-tors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic compari-son. Radiology. 2003;227:371-377. (Pubitemid 36514749)
9. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg. 1982;69: 613-616. (Pubitemid 12038080)
10. Hermanek P, Mansmann U. Criteria for evaluating prognostic factors [in German]. Chirurg. 2001;72:474-480. (Pubitemid 33678645)
11. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative rediochemotherapy. Int J Colo-rectalDis. 1997;12:19-23. (Pubitemid 27138353)
12. Hermanek P, Junginger T, Hossfeld DK, Müller RP, Fölsch UR. Follow up und rehabilitation for patients with gastrointestinal tumors [in German]. Dtsch Aerztblatt. 1999;96:A2084-A2088.
13. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial ofpostoperative radiotherapy and short-term time-sched-uled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian adjuvant rectal cancer project group. Br J Surg. 1997;8:1130-1135 (Pubitemid 27359494)
14. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312:1465-1472
15. Swedish Rectal Cancer Trial. Improved survival with preopera-tive radiotherapy in resectable rectal cancer. N Engl J Med. 1997; 336:980-987.
16. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preop-erative radiotherapy in rectal cancer. N Engl J Med. 2006;355: 1114-1123. (Pubitemid 44394918)
17. Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiother-apy with or without concurrent fluorouracil and leucovorin in T3-4rectalcancers:results ofFFCD 9203.J Clin Oncol. 2006;24: 4620-4625. (Pubitemid 46630960)
18. Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996;3:423-430.
19. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
20. Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor downstaging and sphincter preservation with preoperative chemoradia-tion in locally advanced rectal cancer: The M. D. Andersen Cancer Center experience. Int J Radiat Oncol Biol Phys. 1999; 44:1027-1038. (Pubitemid 29342903)
21. Janjan NA, Crane C, Feig BW, et al. Improved overall survival among responders to preoperative chemoradiation for locally advancedrectalcancer.Am J Clin Oncol. 2001;24:107-112. (Pubitemid 32323343)
22. Biondo S, Navarro M, Marti-Rague J, et al. Response to neoad-juvant therapy for rectal cancer: influence on long-term results. Colorectal Dis. 2005;7:472-479. (Pubitemid 41223142)
23. Kaminsky-Forrett MC, Conroy T, Luporsi E, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys. 1998;42:935-941. (Pubitemid 29004132)
24. García-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Mad-offRD, Rothenberger DA. A pathologic complete response to pre-operative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorec-tal excision. Dis Colon Rectum. 2003;46:298-304. (Pubitemid 36331646)
25. Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preopera-tive chemoradiation for advanced rectal cancer result in de-creased recurrence and improved disease-free survival. Dis Colon Rectum. 2002;45:895-903. (Pubitemid 34761469)
26. Guillem JG, Chessin DB, Cohen AM, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision oflocally advanced rectal cancer. Ann Surg. 2005;241:829-838. (Pubitemid 40604929)
27. Federal Association of German Pathologists. Recommenda-tions for the pathological-anatomical diagnosis of the colo-rectal carcinoma. German Society for Pathologists [in German]. Version1.0 2005. http://www.bvpathologie.de/ mitgliederbereich/files/leitlinien-kolo-karzinom.pdf. Ac-cessed February 2005.
28. Quirke P, Morris E. Reportingcolorectal cancer. Histopathology. 2007;50:103-112.
29. Read TE, McNevin MS, Gross EK, et al. Neoadjuvant therapyfor adenocarcinoma of the rectum: tumor response and acute tox-icity. Dis Colon Rectum. 2001;44:513-522. (Pubitemid 32336425)
30. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer. 2002; 94:1121-1130. (Pubitemid 34150868)
31. Rödel C, Martus P, Papadoupolos T, et al. Prognostic signifi-cance of tumor regression after preoperative chemoradiother-apy for rectal cancer. J Clin Oncol. 2005;23:8688-8696. (Pubitemid 46211512)
32. Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection ofcT3-4 rectal cancer afterpreoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant flu-orouracil-based chemotherapy? A trial of the European Organi-sation for Research and Treatment ofCancer Radiation Oncol-ogy Group. J Clin Oncol. 2007;25:4379-4386. (Pubitemid 350013843)
33. Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors oftumour response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007;9:1750-1755. (Pubitemid 46668536)
34. Lin AY, Wong WD, Shia J, et al. Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy. Int J Colorectal Dis. 2008;23:243-249.
35. Komuro Y, Watanabe T, Hosoi Y, et al. Prediction of tumor radiosensitivity in rectal carcinoma based on p53 and Ku 70 expression.J Exp Clin Cancer Res. 2003;22:223-228. (Pubitemid 36734180)
36. Liersch T, Grade M, Gaedcke J, et al. Preoperative chemoradio-therapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet. 2009;190:57-65.
37. Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free sur-vival in patients with locally advanced rectal cancer. Ann Surg Oncol. 2008;15:2661-2667.
38. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy ofendorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002;45:10-15. (Pubitemid 34072746)
39. Gualdi GF, Casciani E, Guadalaxara A, d'Orta C, Polettini E, Pap-palardo G. Local staging ofrectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with his-tologic findings. Dis Colon Rectum. 2000;43: 338-345. (Pubitemid 30158570)
40. Kim NK, Kim MJ, Yun SH, Sohn SK, Min JS. Comparative study of transrectal ultrasonography, pelvic computerized tomogra-phy, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum. 1999;42:770-775. (Pubitemid 29279429)
41. Kwok H, Bissett IP, Hill GL. Preoperative staging ofrectal can-cer. Int J Colorectal Dis. 2000;15:9-20.
42. Brown G, Davies S, Williams GT, et al. Effectiveness ofpreoper-ative staging in rectal cancer: digital rectal examination, endolu-minal ultrasound or magnetic resonance imaging? Br J Cancer. 2004;91:23-29. (Pubitemid 39013040)
43. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic fac-tors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90:355-364. (Pubitemid 36324117)
44. Winter L, Bruhn H, Langrehr J, Neuhaus P, Felix R, Hänninen LE. Magnetic resonance imaging in suspected rectal cancer: de-termining tumor localization, stage, and sphincter-saving re-spectability at 3 Tesla sustained high resolution. Acta Radiol. 2007;48:379-387. (Pubitemid 46633867)